What is cancer anorexia-cachexia syndrome? A historical perspective

被引:1
|
作者
Bennani-Baiti, N. [1 ]
Walsh, D. [2 ]
机构
[1] Cleveland Clin, Sect Palliat Med & Support Oncol, Taussig Canc Ctr, Cleveland, OH 44106 USA
[2] Cleveland Clin, Harry R Horvitz Ctr Palliat Med, Taussig Canc Ctr, Cleveland, OH 44106 USA
关键词
Anorexia; cachexia; cancer; definition; syndrome;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cancer anorexia-cachexia syndrome (CACS) is a lethal but poorly defined involuntary wasting disorder. Loss of skeletal muscle and fat distinguishes it from starvation. Cachexia has been described as a clinical syndrome since ancient times, and the poor prognosis has long been acknowledged. In this article we have reviewed historical perspectives on cancer cachexia, and commented on modern definitions. In cancer cachexia, most historical descriptions included anorexia, wasting and a pale complexion. Other associated symptoms, such as fatigue, early satiety and taste changes, were inconsistently described. Newer descriptions have not significantly expanded the clinical picture. Today, there is still no consensus definition, hindering research on early diagnosis and effective therapy. The language descriptors used to characterise the syndrome are important. For example, the word 'cachexia' itself may mislead; perhaps cancer-related wasting syndrome is more accurate. Cancer anorexia-cachexia syndrome is a disorder associated with high morbidity and mortality, and deserves greater attention in both clinical and translational research.
引用
收藏
页码:257 / 262
页数:6
相关论文
共 50 条
  • [41] Megestrol acetate in cancer patients with anorexia-cachexia syndrome: a meta-analysis
    Zhan, Ping
    Wang, Qin
    Qian, Qian
    Yu, Li-Ke
    TRANSLATIONAL CANCER RESEARCH, 2013, 2 (02) : 74 - 79
  • [42] Anorexia-cachexia syndrome in pancreatic cancer: Recent advances and new pharmacological approach
    Ronga, Ilaria
    Gallucci, Fernando
    Riccardi, Ferdinando
    Uomo, Generoso
    ADVANCES IN MEDICAL SCIENCES, 2014, 59 (01): : 1 - 6
  • [43] Leveraging a Team Mental Model to Develop a Cancer Anorexia-Cachexia Syndrome Team
    Portman, Diane G.
    Thirlwell, Sarah
    Donovan, Kristine A.
    Alvero, Christine
    Gray, Jhanelle E.
    Holloway, Rosa
    Ellington, Lee
    JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (11) : 1046 - +
  • [44] Cancer anorexia-cachexia syndrome is characterized by more than one inflammatory pathway
    Gagnon, Bruno
    Murphy, Jessica
    Simonyan, David
    Penafuerte, Claudia A.
    Sirois, Jacinthe
    Chasen, Martin
    Tremblay, Michel L.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2024, 15 (03) : 1041 - 1053
  • [45] Corticotropin-Releasing Factor: A Key Element in Cancer Anorexia-Cachexia Syndrome
    Tsai, Minglun
    Fujitsuka, Naoki
    Amitani, Marie S.
    Amitani, Haruka
    Asakawa, Akihiro
    Hattori, Tomohisa
    Kase, Yoshio
    Inui, Akio
    GASTROENTEROLOGY, 2011, 140 (05) : S477 - S477
  • [46] Anamorelin for cancer anorexia-cachexia syndrome: a systematic review and meta-analysis
    Bai, Yu
    Hu, Yunxia
    Zhao, Yanhua
    Yu, Xizhong
    Xu, Junwei
    Hua, Zhiyun
    Zhao, Zhiqiang
    SUPPORTIVE CARE IN CANCER, 2017, 25 (05) : 1651 - 1659
  • [47] Evidence for partial pharmaceutical reversal of the cancer anorexia-cachexia syndrome: the case of anamorelin
    Anker, Stefan D.
    Coats, Andrew J. S.
    Morley, John E.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2015, 6 (04) : 275 - 277
  • [48] Family Members' Explanatory Models of Cancer Anorexia-Cachexia
    McClement, Susan
    HEALTHCARE, 2024, 12 (16)
  • [49] VALIDATION OF CANCER ANOREXIA-CACHEXIA SYNDROME IN GASTROINTESTINAL CANCER: MYTHS OR REALITY AT THAR DESERT OF INDIA
    Sanchetee, S.
    ANNALS OF ONCOLOGY, 2010, 21 : 55 - 55
  • [50] Brainstem GLP-1 signalling contributes to cancer anorexia-cachexia syndrome in the rat
    Borner, Tito
    Liberini, Claudia G.
    Lutz, Thomas A.
    Riediger, Thomas
    NEUROPHARMACOLOGY, 2018, 131 : 282 - 290